期刊文献+

免疫性血小板减少性紫癜患者单个核细胞中microRNA-30a表达增高及其意义 被引量:1

Upregulation of microRNA-30a in peripheral blood mononuclear cells from patients with immune thrombocytopenic purpura and its clinical significance
下载PDF
导出
摘要 目的探讨microRNA-30a是否参与了免疫性血小板减少性紫癜(ITP)的发病机制。方法采用实时荧光定量逆转录-聚合酶链反应(FQ-RT-PCR)技术检测38例ITP患者及35例健康者外周血单个核细胞(PBMC)中microRNA-30a和Lyn mRNA的相对表达量,并进行统计分析。结果 ITP患者外周血PBMC中microRNA-30a表达较健康对照组明显增高(P<0.01),且与血小板计数呈负相关(r2=0.42,P<0.05);ITP患者外周血PBMC中Lyn mRNA表达较健康对照组明显降低(P<0.01),且与microRNA-30a呈负相关(r2=0.33,P<0.01)。结论 microRNA-30a可能通过Lyn参与了ITP的发病机制。 Objective To investigate whether microRNA-30a may play a role in the pathogenesis of immune thrombocytopenic purpura(ITP). Methods The expression of microRNA-30a in the peripheral blood mononuelear cells(PBMCs) in 38 ITP patients and 35 healthy individuals were detected by RT-PCR. The confirmed target expression of microRNA-30a and Lyn mRNA were de- tected. The association between microRNA-30a and platelet count of ITP was analyzed. Results The expression of microRNA-30a in PBMCs from patients with ITP was increased significantly in contrast to the healthy controls(P〈0. 01 ), and was negatively correlated with platelet count. The expression of Lyn mRNA was significantly reduced, compared to control subjects(P〈0.01) ,and was negatively associ- ated with microRNA-30a. Conclusion MicroRNA-30a may play a role in the pathogenesis of ITP and was a potential marker for it.
出处 《国际检验医学杂志》 CAS 2013年第24期3308-3309,3311,共3页 International Journal of Laboratory Medicine
基金 国家重点基础研究发展计划(973)资助项目(2013CB531606) 国家自然科学基金资助项目(81273282 81202353 30972730) 上海科委基金资助项目(11JC1410902) 吴阶平基金资助项目(320.6750.13147) 上海杨浦区人才发展资金资助项目(鼎元资金) 长海医院基金资助项目(CH125530300)
关键词 免疫性血小板减少性紫癜 microRNA-30a 实时荧光定量逆转录PCR immune thrombocytopenic purpural microRNA-30a RT-PCR
  • 相关文献

参考文献16

  • 1Cines DB,Blanchette VS. Immune thrombocytopenic purpura[J]. N Engl J Med,2002,346(13) :995-1008.
  • 2Barnard D, Woloski M, Feeny D, et al. Development of disease- specific health-related quality-of life instruments for children with immune thrombocytopenic purpura and their parents[J]. J Pediatr Hematol Oncol,2003,5(1) :5662.
  • 3Psaila B, Bussel JB. Immune thrombocytopenic purpura[J]. He- matol Oncol Clin North Am,2007,21(4):743-759.
  • 4BarteI DP. MicroRNAs: target recognition and regulatory func- tions[J]. Cell,2009,136(2) :215-233.
  • 5Kasinski AL, Slack FJ. Epigenetics and genetics. MieroRNAs en route to the clinic: pro-gress in validating and targeting microR- NAs for cancer therapy [J]. Nat Rev Cancer, 2011,11 (12) : 849- 864.
  • 6Pauley KM,Cha S,Chan EK. MicroRNA in autoimmunity and au- toimmune diseases[J]. J Autoimmun,2009,32(3) : 189-194.
  • 7O' Connell RM, Rao DS, Chaudhuri AA, et al. Sustained expres- sion of microRNA-155 in hematopoietic stem cells causes a myelo- proliferativedisorder[J]. J Exp Med, 2008,205 (3) : 585-594.
  • 8Taganov KD, Boldin MP, Chang KJ, et al. NF-xB-dependent in diaction of mieroRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses[J]. Proc Natl Acad Sci U S A, 2006,103(33) : 12481-12486.
  • 9Liu Y, Dong J, MuR, et al. MicroRNA-30a promotes B cell hyper activity in patients with Systemic lupus erythematosus by direct interaction with Lyn[J]. Arthritis Rheum, 2013, 65(6),1603-1611.
  • 10成人原发免疫性血小板减少症诊治的中国专家共识(修订版)[J].中华血液学杂志,2011,32(3):214-216. 被引量:206

共引文献205

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部